LFB (United States)

Recent papers from LFB (United States)

1. Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 studyBlood Vessels Thrombosis & Hemostasis · 2026
2. Public priorities for primary care in CanadaCanadian Family Physician · 2025
3. Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitorsHaemophilia · 2024
4. Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitorsHaemophilia · 2022
5. The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitorsHaemophilia · 2021
6. PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitorsHaemophilia · 2021
7. Exploratory in vitro evaluation of thrombin generation of eptacog beta (recombinant human fviia) and emicizumab in congenital haemophilia A plasmaHaemophilia · 2021
8. Cetuximab produced from a goat mammary gland expression system is equally efficacious as innovator cetuximab in animal cancer modelsBiotechnology Reports · 2020
9. Transgenic goats producing an improved version of cetuximab in milkFASEB BioAdvances · 2020
10. Transgenic goats producing an improved version of cetuximab in milk2020
11. Cetuximab produced from a goat mammary gland expression system is equally efficacious as innovator cetuximab in model systems of cancer2020
12. Passive Immunity to Vibrio cholerae O1 Afforded by a Human Monoclonal IgA1 Antibody Expressed in MilkPathogens and Immunity · 2020
13. Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMOCritical Care · 2020
14. Increased Accumulation and Retention of rhFVIIa (eptacog beta) in Knee Joints of Hemophilia A Mice Compared to Wild-Type MiceThrombosis and Haemostasis · 2019
15. Fc Sialylation Prolongs Serum Half-Life of Therapeutic AntibodiesThe Journal of Immunology · 2019
16. Intravenous immunoglobulin for treatment of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in France: are daily practices in accordance with guidelines?European Journal of Neurology · 2018
17. Johne's disease: a successful eradication programme in a dairy goat herdVeterinary Record · 2018
18. Safety and dose‐dependency of eptacog beta (activated) in a dose escalation study of non‐bleeding congenital haemophilia A or B patients, with or without inhibitorsHaemophilia · 2017
19. PERSEPT 1: a phase 3 trial of activated eptacog beta for on‐demand treatment of haemophilia inhibitor‐related bleedingHaemophilia · 2017
20. Kinetic analysis and binding studies of a new recombinant human factor VII a for treatment of haemophiliaHaemophilia · 2016